Phreesia, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023
December 05, 2023 at 04:03 pm EST
Share
Phreesia, Inc. reported earnings results for the third quarter and nine months ended October 31, 2023. For the third quarter, the company reported sales was USD 25.81 million compared to USD 20.49 million a year ago. Revenue was USD 91.62 million compared to USD 73.1 million a year ago. Net loss was USD 31.94 million compared to USD 40.17 million a year ago. Basic loss per share from continuing operations was USD 0.58 compared to USD 0.76 a year ago.
For the nine months, sales was USD 70.41 million compared to USD 52.57 million a year ago. Revenue was USD 261.29 million compared to USD 204.32 million a year ago. Net loss was USD 106.24 million compared to USD 138.13 million a year ago. Basic loss per share from continuing operations was USD 1.96 compared to USD 2.64 a year ago.
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. The Company also provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
PHREESIA, INC. 
